Les Laboratoires Majorelle
Making innovation accessible
Our expertise
The laboratory offers its expertise in the development and marketing of healthcare products for patients and health professionals, particularly in the fields of women's health and sexual health.
Our mission
Majorelle is a team of passionate women and men committed to bringing innovative therapeutic solutions that are accessible to all. Their approach is based on the belief that it's necessary to make essential molecules and medical devices available to as many people as possible to address medical conditions that affect women's health and sexual health
Our key figures
Oral birth control in France:
2 million women take a Laboratoires Majorelle birth control pill every day.
Health professionals in France are supported by our field teams throughout the country.
Therapies available to patients.
Our history
The Laboratoire Majorelle story began in 2012 with the inauguration of the laboratory and the launch of Optilova, a 2nd generation continuous-use pill in France.
Optimizette, the first desogestrel pill to be covered by social security without any additional risks of DVT.
Majorelle becomes a key player in the sexual health sphere with the launch of the first treatment for erectile dysfunction to come in cream form (Vitaros 1, 2).
Majorelle becomes the birth control market leader.
Eden is launched as the first condom to be covered by social security with a prescription, and the Assanis and Maternov brands are acquired.
Majorelle is committed to the sexual health of young people and launches its Eden Gen range in combination with the Sextember campaign.
EDEN condoms are available in all pharmacies free of charge to under 26s.